FDA Inspection 1015913 — Beth Israel Deaconess Medical Center IRB
The FDA completed an inspection of Beth Israel Deaconess Medical Center IRB on May 25, 2017 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 25, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
IRB